Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
Autor: | Swee Lay Thein, Ageliki Gerovassili, Chad Garner, Kypros H. Nicolaides, David C. Rees |
---|---|
Rok vydání: | 2006 |
Předmět: |
Male
Pathology medicine.medical_specialty Aneuploidy Prenatal diagnosis Chromosome Disorders Biology Polymerase Chain Reaction Andrology Fetus Pregnancy Prenatal Diagnosis medicine Humans Prospective Studies Prospective cohort study Maternal-Fetal Exchange Genetics (clinical) Crown-rump length Obstetrics and Gynecology DNA medicine.disease Fetal Blood Prognosis Sex-Determining Region Y Protein Fetal Diseases Pregnancy Trimester First Cell-free fetal DNA Female Trisomy Biomarkers |
Zdroj: | Prenatal diagnosis. 27(2) |
ISSN: | 0197-3851 |
Popis: | Objectives Previous studies on the association of fetal cell-free (cf)DNA levels in maternal circulation have produced conflicting results but the sample sizes were small and based on archived material. We aimed to quantify the levels of fetal and total cfDNA on prospectively collected samples, to understand their correlation with other variables and to clarify their diagnostic value. Methods DNA from pre-CVS maternal plasma was extracted from 264 controls, 72 trisomy 21, 24 trisomy 18, 12 trisomy 13, 16 Turner's syndrome and 8 triploidy first-trimester pregnancies and quantified using real-time PCR. β-globin was used to determine total cfDNA levels and DYS14 and SRY assays to determine fetal cfDNA levels. Results Fetal cfDNA levels (DYS14) showed correlation with crown rump length (CRL) (p = 0.004), BMI (p = 0.01) and storage time (p = 0.007) while there was an inverse correlation of total cfDNA levels with nuchal translucency (NT) (p = 0.001). No significant difference was observed between the levels of fetal cfDNA in controls and aneuploidy cases. Conclusion Quantification of fetal and total cfDNA in maternal circulation showed inverse correlation between NT and total cfDNA levels. Our results also suggest that fetal cfDNA is not an ideal prognostic marker for chromosomal abnormalities in first-trimester pregnancies. Copyright © 2006 John Wiley & Sons, Ltd. |
Databáze: | OpenAIRE |
Externí odkaz: |